According to SEC filings for the period ending December 2025, Lineage Cell Therapeutics, Inc. (NYSE:LCTX) is held by 120 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 31 Dec, 2025 | 49,560,992 | 0 | 0.00% | $82,766,857.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 9,644,276 | 637,346 | 7.08% | $16,105,941.00 |
| Defender Capital, LLC. | 31 Dec, 2025 | 6,829,099 | 6,829,099 | 0.00% | $11,405,031.00 |
| RAFFLES ASSOCIATES LP | 31 Dec, 2025 | 5,362,788 | -25,000 | -0.46% | $8,955,856.00 |
| COMERICA BANK | 31 Dec, 2025 | 4,600,000 | 0 | 0.00% | $7,682,000.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,834,113 | 1,603,357 | 71.88% | $6,402,969.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,461,193 | 41,427 | 1.71% | $4,112,193.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 2,404,800 | 499,167 | 26.19% | $4,016,016.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 2,110,419 | -569,584 | -21.25% | $3,524,400.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 1,998,663 | 992,212 | 98.59% | $3,337,767.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 1,438,746 | 1,294,070 | 894.46% | $2,402,706.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 1,362,061 | 1,362,061 | 0.00% | $2,274,642.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,016,211 | 60,589 | 6.34% | $1,697,072.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 1,004,794 | 835,831 | 494.68% | $1,678,007.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 706,415 | 521,415 | 281.85% | $1,179,713.00 |
| RED CRANE WEALTH MANAGEMENT, LLC | 31 Dec, 2025 | 597,263 | 85,900 | 16.80% | $997,429.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 507,052 | 313,084 | 161.41% | $846,777.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 479,273 | 35,921 | 8.10% | $800,386.00 |
| Informed Momentum Co LLC | 31 Dec, 2025 | 442,221 | 0 | 0.00% | $738,509.00 |
| BARCLAYS PLC | 31 Dec, 2025 | 348,510 | 348,509 | 34,850,900.00% | $582,012.00 |